Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “SION”

1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,496
Index total 30,257
Page 42 / 63

Quick answer

This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,496 results for “SION” · 30,257 patents in full index Clear search

  1. US 8877208

    Multivalent nanoemulsion vaccines

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  2. US 8877726

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  3. US 8865430

    Fusion polypeptides capable of activating receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted

  4. US 8859516

    Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes

    Alnylam Pharmaceuticals, Inc. · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  5. US 8859499

    Method of enhancing efficacy of blood transfusions

    The Regents of the University of California · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  6. US 8859527

    Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treatment of cancer thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  7. US 8859585

    Scopolamine for the treatment of depression and anxiety

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  8. US 8858945

    Three-dimensional structure of complement receptor type 2 and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  9. US 8853271

    Method for inhibiting activity and/or expression of matrix metalloproteinase, inhibiting phosphorylation of mitogen-activated protein kinase, and/or promoting expression of collagen using tormentic acid

    China Medical University · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

  10. US 8840978

    Identification device having antimicrobial properties

    Precision Dynamics Corporation · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  11. US 8828725

    Culture medium

    HON HAI PRECISION INDUSTRY CO., LTD. · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  12. US 8808866

    Coated elastomeric article and method for making a coated elastomeric article

    Precision Components, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  13. US 8809515

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  14. US 8809293

    Compositions and methods for inhibiting gene expression of hepatitis B virus

    Arrowhead Madison, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  15. US 8809292

    Compositions and methods for inhibiting expression of the PCSK9 gene

    Alnylam Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  16. US 8802090

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted

  17. US 8796444

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  18. US 8791250

    Compositions and methods for inhibiting expression of the HAMP gene

    Alnylam Pharmaceuticals, Inc. · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  19. US 8785609

    Cloning and expression of HTLV-III DNA

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  20. US 8784780

    High oil-content emollient aerosol foam compositions

    Precision Dermatology, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  21. US 8779094

    Low viscosity highly concentrated suspensions

    The Board of Regents of the University of Texas System · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  22. US 8781750

    Cell-type-specific patterns of gene expression

    The Regents of the University of California · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  23. US 8771731

    Antimicrobial nanoemulsion compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted

  24. US 8765932

    Compositions and methods for inhibiting expression of XBP-1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.